查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197768

閉塞器械市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Occlusion Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，封堵器械市場的複合年增長率預計為 7.5%。

COVID-19 大流行影響了各種外科手術。 在患有各種與生活方式相關的疾病和慢性疾病的患者中，觀察到診斷和治療的延誤是由於隔離導致的醫院就診次數減少，從而影響了所研究的市場。 例如，根據 2020 年 8 月發表的一項研究，COVID-19 大流行對加拿大的介入放射學服務產生了負面影響，尤其是擇期病例。 調查顯示，約49.3%的受訪者表示，國內的介入放射服務整體呈下降趨勢。 數據顯示，大流行減少了手術程序，這影響了封堵器市場。 然而，疫苗接種和 COVID-19 病例數的下降已經完全反彈了所研究的市場。

推動市場增長的主要因素包括微創手術 (MIS) 的接受率高於傳統手術、生活方式病和慢性病的增加以及該領域的技術進步。 例如，根據一份 2021 年世衛組織情況說明書，非傳染性疾病 (NCD)，也稱為慢性病，每年導致約 4100 萬人死亡，2021 年全球記錄的死亡人數約佔所有死亡人數的 71%。 根據同一消息來源，全世界每年有超過 1500 萬 30-69 歲的人死於非傳染性疾病。 因此，非傳染性疾病造成的高死亡負擔增加了對治療的需求。 因此，預計該市場將在預測期內擴大。

MIS 的日益普及預計將推動整個市場的增長。 MIS 的特點是術後疼痛較輕。 此外，憑藉最少的切口和縫合線以及相對較短的住院時間，該技術已證明其在執行複雜手術中的效率。

然而，產品的高成本和對熟練專業人員的需求阻礙了市場的增長。

封堵器市場趨勢

神經學領域的預期增長

腦動脈瘤患病率的上升和新技術產品的推出預計將推動整個市場的增長。 根據 Brain Aneurysm Foundation 的估計，到 2021 年，美國每年約有 30,000 人患有腦動脈瘤破裂。

腦動脈瘤的形成因素包括血管損傷/外傷、吸煙、高血壓和遺傳易感性。 腦動脈瘤的治療包括藥物治療、手術夾閉或血管內治療，或者在有或沒有輔助裝置的情況下進行捲繞。 例如，根據 2021 年 8 月的 WHO Key Facts，全球估計有 12.8 億 30-79 歲的成年人患有高血壓，其中大多數（三分之二）在低收入和中等收入國家。這是增長背後的推動力段的。

根據同一消息來源，尤其是 55 歲以上的女性患腦動脈瘤破裂的風險高於男性。 隨著人口老齡化的增加，這種風險預計會在未來增加。 根據聯合國2020年發布的數據，全球60歲及以上人口預計將從2020年的13.2%增長到2050年的21.3%。 預計這會增加動脈瘤的發生率。 因此，發病率上升有望幫助市場增長。

預計在預測期內北美將佔據最大的市場份額

由於微創手術的普及和醫療基礎設施的加強，北美有望成為最大的封堵器市場。 此外，新型封堵器獲批的增加也有望推動整體市場增長。 市場參與者 Abbott Laboratories 於 2020 年 11 月獲得 FDA 批准的 Amplatzer Piccolo 封堵器，該封堵器用於通過微創手術治療動脈導管未閉的嬰兒。這將是世界上第一個植入式醫療設備。

越來越多的心血管疾病病例也創造了對該產品的需求並促進了市場的增長。 例如，根據美國疾病預防控制中心 2021 年 9 月發布的數據，心髒病是美國的首要死因。 20歲以上成年人約有1820萬人患有冠心病，2019年約有36.09萬人死於冠心病。 因此，由於該國心血管疾病的死亡率很高，預計手術數量將會增加，這有望促進封堵器的採用並促進市場的增長。

癌症也是該國最常見的慢性病之一，預計未來幾年將進一步推動市場增長。 例如，根據 GLOBOCAN 2020 報告，2020 年美國將報告 101,809 例結腸癌病例、44,780 例直腸癌病例和 26,259 例胃癌病例。 預計這將推動該國對乾預措施的需求。 因此，由於上述因素，預計市場在預測期內將出現高增長。

封堵器市場競爭對手分析

由於少數主要市場參與者的存在，封堵器市場正在整合。 一些市場參與者是雅培實驗室、波士頓科學公司、BTG 國際有限公司、愛德華茲生命科學公司、強生公司、美敦力 PLC、梅裡特醫療系統公司、Penumbra Inc.、Stryker Corporation、Penumbra Inc 和 Terumo Corporation。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 越來越多地採用微創手術
    • 不斷增長的老年人口和不斷增加的慢性病負擔
    • 技術進步
  • 市場製約因素
    • 產品成本高
    • 需要熟練的專業人員
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品分類
    • 閉塞去除裝置
      • 線圈獵犬
      • 支架回收器
      • 其他
    • 栓塞裝置
    • 支持的設備
  • 通過申請
    • 外周血管疾病
    • 神經
    • 腫瘤科
    • 泌尿科
    • 其他應用
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • BTG International Ltd
    • Edwards Lifesciences Corporation
    • Johnson & Johnson
    • Medtronic PLC
    • Merit Medical Systems
    • Penumbra Inc.
    • Stryker Corporation
    • Terumo Corporation
    • Lepu Medical Technology
    • LeMaitre Vascular Inc.

第7章 市場機會今後動向

簡介目錄
Product Code: 66840

The occlusion devices market is expected to register a CAGR of 7.5% during the forecast period.

The COVID-19 pandemic had ramifications on various surgical procedures. Due to the lockdown restrictions, a delay in diagnosis and treatments was observed in patients with various lifestyle-related and chronic diseases as a result of a reduction in hospital visits, which impacted the market studied. For instance, according to the research study published in August 2020, the COVID-19 pandemic negatively impacted interventional radiology services in Canada, especially for elective cases. As per the study, about 49.3% of the respondents reported that there was an overall decline in interventional radiology services in the country. Thus, this data indicates that surgical procedures declined due to the pandemic scenario, which, in turn, affected the occlusion devices market. However, due to the vaccinations and declining cases of COVID-19, the market studied has bounced back to its full potential.

The major factors for the growth of the market include the higher acceptance rate of minimally invasive surgeries (MIS) over traditional surgeries, the increasing prevalence of lifestyle-related and chronic diseases, and technological advancements in the area. For instance, according to the WHO fact sheet of 2021, non-communicable diseases (NCDs), also known as chronic diseases, are responsible for the death of about 41 million people each year, which was about 71% of the total deaths recorded all over the world in 2021. As per the same source, every year, over 15 million people aged between 30-69 die due to NCDs across the world. Therefore, the demand for treatment procedures is increasing owing to the high burden of mortality due to NCDs. Thus, the market studied is expected to grow over the forecast period.

The rising adoption of MIS is expected to drive the overall growth of the market. MIS cause less post-operative pain. Besides, there are minimal cuts or stitches involved, the hospital stay is relatively shorter, and this technology is proving its efficiency in treatment while performing complex surgeries.

However, the high cost of the products and the requirement for skilled professionals are hampering the growth of the market.

Occlusion Devices Market Trends

Neurology Segment is Expected to Witness a Lucrative Growth

The rising prevalence of brain aneurysms and the launch of new technologically advanced products are expected to drive the overall growth of the market. According to 2021 estimates by the Brain Aneurysm Foundation, approximately 30,000 people in the United States suffer a brain aneurysm rupture each year.

Factors contributing to the formation of a brain aneurysm are injury/trauma to blood vessels, smoking, hypertension, and genetic predisposition. The treatment of brain aneurysms includes medical therapy, surgical clipping or endovascular therapy, or coiling without or with adjunctive devices. For instance, as per the WHO's key facts of August 2021, an estimated 1.28 billion adults aged 30-79 years worldwide were living with hypertension, most (two-thirds) living in low- and middle-income countries, which is driving the segmental growth.

The same source stated that women, particularly those over the age of 55, have a higher risk of brain aneurysm rupture than men. This risk is expected to increase in the future as the geriatric population increases. As per the UN data published in 2020, the global population aged 60 years or above is anticipated to increase from 13.2% in 2020 to 21.3% by 2050. This is expected to raise the incidence of aneurysms. Hence, the rising incidence is expected to help the market's growth.

North America is Expected to Hold Largest Market Share over the Forecast Period

North America is expected to be the largest occlusion devices market owing to the rising adoption of minimally invasive surgeries and better healthcare infrastructure. Furthermore, the rising approval of new occlusion devices is expected to boost the overall growth of the market. One of the market players, Abbott Laboratories, received approval from FDA for the Amplatzer Piccolo Occluder in November 2020, which is the world's first medical device that can be implanted in babies using a minimally invasive procedure to treat patent ductus arteriosus.

The increasing cases of cardiovascular diseases are also generating demand for the product, which is fuelling the market's growth. For instance, as per the CDC's data published in September 2021, heart disease was the leading cause of death in the United States. About 18.2 million adults of age 20 years and older had coronary artery disease, and about 360,900 people died in 2019 due to coronary heart disease. Thus, due to the high mortality rate caused by cardiovascular diseases in the country, the number of surgeries is expected to increase, which, in turn, is likely to boost the adoption of occlusion devices, thereby contributing to the market's growth.

In addition, cancer is also one of the most prevalent chronic diseases in the country, which is further expected to augment the growth of the market over the years. For instance, according to the GLOBOCAN 2020 Report, 101,809 cases of colon cancer, 44,780 cases of rectum cancer, and 26,259 cases of stomach cancer were reported in the United States in 2020. This is expected to drive the demand for interventional procedures in the country. Thus, owing to the factors mentioned above, the market is expected to witness high growth over the forecast period.

Occlusion Devices Market Competitor Analysis

The occlusion devices market is consolidated owing to the presence of a few major market players. Some of the market players are Abbott Laboratories, Boston Scientific Corporation, BTG International Ltd, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Penumbra Inc., Stryker Corporation, Penumbra Inc., and Terumo Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Adoption of Minimally Invasive Surgeries
    • 4.2.2 Increasing Geriatric Population and Rising Burden of Chronic Diseases
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Products
    • 4.3.2 Requirement of Skilled Professionals
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Occlusion Removal Devices
      • 5.1.1.1 Coil Retrievers
      • 5.1.1.2 Stent Retrievers
      • 5.1.1.3 Other Occlusion Removal Devices
    • 5.1.2 Embolization Devices
    • 5.1.3 Support Devices
  • 5.2 By Application
    • 5.2.1 Peripheral Vascular Disease
    • 5.2.2 Neurology
    • 5.2.3 Oncology
    • 5.2.4 Urology
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 BTG International Ltd
    • 6.1.4 Edwards Lifesciences Corporation
    • 6.1.5 Johnson & Johnson
    • 6.1.6 Medtronic PLC
    • 6.1.7 Merit Medical Systems
    • 6.1.8 Penumbra Inc.
    • 6.1.9 Stryker Corporation
    • 6.1.10 Terumo Corporation
    • 6.1.11 Lepu Medical Technology
    • 6.1.12 LeMaitre Vascular Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS